<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>领星GenomiCare | wechat-feeds</title><link>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</link><description>领星是由中美生物医学数据科学家携手高年资肿瘤专家共同开创的临床科技和数据平台，提供肿瘤精准医疗和数据智能服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 18 Mar 2021 11:19:13 +0800</pubDate><image><url>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</url><title>领星GenomiCare | wechat-feeds</title><link>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>科普丨肝癌患者如何进行康复管理？</title><link>https://mp.weixin.qq.com/s/bRJOInkJBMGR5IslE22kwA</link><description></description><content:encoded><![CDATA[科普丨肝癌患者如何进行康复管理？]]></content:encoded><pubDate>Thu, 18 Mar 2021 11:00:48 +0800</pubDate></item><item><title>速递丨创新肾细胞癌疗法获FDA优先审评资格</title><link>https://mp.weixin.qq.com/s/puvAMWSHqBTRzw8KrngrGA</link><description></description><content:encoded><![CDATA[速递丨创新肾细胞癌疗法获FDA优先审评资格]]></content:encoded><pubDate>Thu, 18 Mar 2021 11:00:48 +0800</pubDate></item><item><title>临床试验丨 结直肠癌（一）</title><link>https://mp.weixin.qq.com/s/kmIODvfJOAxhGVhi7nGYVA</link><description></description><content:encoded><![CDATA[临床试验丨 结直肠癌（一）]]></content:encoded><pubDate>Wed, 17 Mar 2021 11:08:15 +0800</pubDate></item><item><title>阿法替尼+西妥昔单抗治疗非小细胞肺癌可能并非越早越好</title><link>https://mp.weixin.qq.com/s/dnV30I8j_2JWZgr7vcwT_g</link><description></description><content:encoded><![CDATA[阿法替尼+西妥昔单抗治疗非小细胞肺癌可能并非越早越好]]></content:encoded><pubDate>Tue, 16 Mar 2021 11:17:47 +0800</pubDate></item><item><title>速递丨FDA批准新一代VEGF受体抑制剂</title><link>https://mp.weixin.qq.com/s/9QKJ4nz35C8Lct5VTP0r_w</link><description></description><content:encoded><![CDATA[速递丨FDA批准新一代VEGF受体抑制剂]]></content:encoded><pubDate>Tue, 16 Mar 2021 11:17:47 +0800</pubDate></item><item><title>不同抗体检测的 PD-L1，可相互通用吗？</title><link>https://mp.weixin.qq.com/s/H2dNRBE-omXd9vKQE2SjBA</link><description></description><content:encoded><![CDATA[不同抗体检测的 PD-L1，可相互通用吗？]]></content:encoded><pubDate>Fri, 12 Mar 2021 09:22:56 +0800</pubDate></item><item><title>世界肾脏日丨无法进行手术的肾癌患者该怎么办？</title><link>https://mp.weixin.qq.com/s/4srW8rnsshLJxRBmIFzEKQ</link><description></description><content:encoded><![CDATA[世界肾脏日丨无法进行手术的肾癌患者该怎么办？]]></content:encoded><pubDate>Thu, 11 Mar 2021 10:53:28 +0800</pubDate></item><item><title>速递丨国内首款埃博霉素类1类新药优替德隆注射液即将获批</title><link>https://mp.weixin.qq.com/s/VV2Z0KS9cAMh4UZtpJEkxw</link><description></description><content:encoded><![CDATA[速递丨国内首款埃博霉素类1类新药优替德隆注射液即将获批]]></content:encoded><pubDate>Thu, 11 Mar 2021 10:53:28 +0800</pubDate></item><item><title>临床试验丨 胃癌（六）</title><link>https://mp.weixin.qq.com/s/YkDbQZdLdhc5K6khFDcNBw</link><description></description><content:encoded><![CDATA[临床试验丨 胃癌（六）]]></content:encoded><pubDate>Wed, 10 Mar 2021 09:34:08 +0800</pubDate></item><item><title>nature genetics：WES分析揭示多癌种基因突变图谱及扩散时间</title><link>https://mp.weixin.qq.com/s/G4S0PBIsRjiAgu3LcEoBsg</link><description></description><content:encoded><![CDATA[nature genetics：WES分析揭示多癌种基因突变图谱及扩散时间]]></content:encoded><pubDate>Tue, 09 Mar 2021 13:53:16 +0800</pubDate></item><item><title>速递丨辉瑞lorlatinib新适应症获批；首个Claudin18.2/PD-L1双抗获批临床</title><link>https://mp.weixin.qq.com/s/cpwAc824PtSrkNdYeHwMkQ</link><description></description><content:encoded><![CDATA[速递丨辉瑞lorlatinib新适应症获批；首个Claudin18.2/PD-L1双抗获批临床]]></content:encoded><pubDate>Tue, 09 Mar 2021 13:53:16 +0800</pubDate></item><item><title>都是免疫治疗，PD-1 和 PD-L1 抑制剂到底有什么区别？</title><link>https://mp.weixin.qq.com/s/WT2fejKmSBYLsu36zwucIA</link><description></description><content:encoded><![CDATA[都是免疫治疗，PD-1 和 PD-L1 抑制剂到底有什么区别？]]></content:encoded><pubDate>Thu, 04 Mar 2021 11:34:41 +0800</pubDate></item><item><title>速递丨辉瑞BRAF抑制剂在中国获批临床</title><link>https://mp.weixin.qq.com/s/xzCf5xi2oxiC7pmp1OLJIA</link><description></description><content:encoded><![CDATA[速递丨辉瑞BRAF抑制剂在中国获批临床]]></content:encoded><pubDate>Thu, 04 Mar 2021 11:34:41 +0800</pubDate></item><item><title>临床试验 | 胃癌（五）</title><link>https://mp.weixin.qq.com/s/ANzus-wyE3hL3QWUcZ2xSw</link><description></description><content:encoded><![CDATA[临床试验 | 胃癌（五）]]></content:encoded><pubDate>Wed, 03 Mar 2021 11:16:11 +0800</pubDate></item><item><title>文献精读丨单细胞多组学揭示结直肠癌基因突变图谱</title><link>https://mp.weixin.qq.com/s/cZCtvlTs8PAXu-P6hmV4Xg</link><description></description><content:encoded><![CDATA[文献精读丨单细胞多组学揭示结直肠癌基因突变图谱]]></content:encoded><pubDate>Tue, 02 Mar 2021 11:08:45 +0800</pubDate></item><item><title>速递丨默沙东从康方生物引进的CTLA-4单抗联合疗法在华获批临床</title><link>https://mp.weixin.qq.com/s/dkI019ymB34-JM5Y6CuUaA</link><description></description><content:encoded><![CDATA[速递丨默沙东从康方生物引进的CTLA-4单抗联合疗法在华获批临床]]></content:encoded><pubDate>Tue, 02 Mar 2021 11:08:45 +0800</pubDate></item></channel></rss>